• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Too Little Sleep Destroys DNA?
I talk to my patients about the danger of not sleeping all the time. Unfortunately, it’s a common problem that affects 75 million Americans. People who don’t sleep, or sleep poorly, have up to 400% more accidents that those who get a good night’s rest. Not getting enough sleep also increases your risk of developing chronic diseases. Studies, including a large meta-analysis of 470,000 adults, found that those who slept less than six hours developed a:1,2,3,4,5 48% increase in the incidence of coronary heart disease 30% increased risk of dementia 15% increase in the incidence of stroke 50% cancer risk 17% higher risk ...
Source: Al Sears, MD Natural Remedies - August 25, 2023 Category: Complementary Medicine Authors: Jacob Tags: Anti-Aging Health Source Type: news

Stem cell survival after transplantation impacted by melatonin pre-treatment
When melatonin, a hormone secreted by the pineal gland, was used as a pre-treatment for mesenchymal stem cells (MSCs) prior to their transplantation into the brains of laboratory animals to repair damage from stroke, researchers in China found that the stem cells survived longer after transplantation. Previous studies had shown that 80 percent of transplanted MSCs died within 72 hours of transplantation. By contrast, the melatonin pre-treatment "greatly increased" cell survival, said the researchers...
Source: Health News from Medical News Today - July 24, 2013 Category: Consumer Health News Tags: Stroke Source Type: news

Melatonin pre-treatment is a factor that impacts stem cell survival after transplantation
(Cell Transplantation Center of Excellence for Aging and Brain Repair) Melatonin used as a pre-treatment for mesenchymal stem cells, prior to their transplantation into the brains of laboratory animals to repair damage from stroke, helped stem cells survive longer after transplantation. The melatonin pre-treatment greatly increased cell survival when contrasted with previous studies in which 80 percent of transplanted MSCs died within 72 hours of transplantation. Study results demonstrated that the melatonin pre-treated MSCs had enhanced survival under oxidative stimulation by activating the Erk1/2 pathway.
Source: EurekAlert! - Medicine and Health - July 22, 2013 Category: Global & Universal Source Type: news